Cano Health
Closed (deSPAC)Health Care · value-based primary care for Medicare Advantage members · founded 2009
- What it is
- Health Cano Health (NYSE: CANO) is a high-touch, technology-powered healthcare company delivering personalized, value-based primary care to more than 270,000 members
- What it’s doing now
- Merging with Jaws Acquisition Corp. (JWS) — closed (despac).
- What you should know
- Data is still being assembled for this company — what is shown below is everything we have verified so far.
The business, per its filings
SEC primaryHealth Cano Health (NYSE: CANO) is a high-touch, technology-powered healthcare company delivering personalized, value-based primary care to more than 270,000 members. With its headquarters in Miami, Florida, Cano Health is transforming healthcare by delivering primary care that measurably improves the health, wellness, and quality of life of its patients and the communities it serves. Founded in 2009, Cano Health has more than 4,000 employees, and operates primary care medical centers and supports affiliated providers in eight states and Puerto Rico. For more information, visit canohealth.com or investors.canohealth.com .
Source: S-4/A, accession 0001193125-21-137771
What the company says about itself
Web research — not auditedCano Health provides compassionate primary care and wellness services through a network of medical centers in Florida. The company offers comprehensive care including pediatric care, primary care, laboratory and diagnostics, care management, pharmacy, social services, health and wellness, therapy services, and transportation services. They also provide a secure Patient Portal for managing appointments and accessing medical records.
- Markets:
- Healthcare | Primary Care | Pediatric Care | Pharmacy | Social Services
- Products:
- Medical Center Network | Patient Portal | Cano Pediatrics | Primary Care | Laboratory & Diagnostics | Care Management | Pharmacy | Social Services | Health & Wellness | Therapy Services & Specialties | Transportation Service
[WEB-INTEL 2026-08-26] 3 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The transaction values Cano Health at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds" [https://www.goodwinlaw.com/en/news-and-events/news/2020/11/11_12-cano-health-to-merge-with-spac-jaws] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Deal Size, $M $4,695.00M" [https://www.spacresearch.com/symbol/JWS.U] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Closing Date Jun 3, 2021" [https://www.spacresearch.com/symbol/JWS.U]
Source: https://canohealth.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
Cano Health is merging with Jaws Acquisition Corp. (JWS) currently marked Closed (deSPAC).
| Headline equity value | — |
| PIPE | ≈ $800M · unsourced |
Structure per SEC accession(s) 0001193125-21-016498. How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Common questions
Is Cano Health going public?
Cano Health has an approved merger with the SPAC Jaws Acquisition Corp. (JWS). Deal status: Closed (deSPAC).
Does Cano Health have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.
- Oak Hill Bio — with RACC ($160M) · pre-revenue
- Longevity Biomedical — with FTII ($100M) · pre-revenue
- GNQ Insilico — with IBAC ($500M)
- HCC Healthcare Pte. — with RFAM ($500M)
- OmniAb — with AHPA
- Jasper Therapeutics — with AMHC